StreetAlpha.app
Home › Stocks › QTRX

Quanterix Corp (QTRX)

$1.96
▼ −3.45%
LAST CLOSE · NOV 20

Quanterix makes instruments, consumables and tests that detect protein biomarkers for research labs, drug developers and clinical use. It last closed at $1.96 on Nov 20, down 3.45% on the day. The next earnings report for QTRX is expected around Mon, Mar 1, 2027, after the close. For the quarter ended Sep 2026, QTRX reported EPS of -$0.46 on revenue of $35.0M, with revenue down 13.1% from a year ago. Over its last 8 reports the stock moved an average of 17.4% the session after earnings. Over the last 12 months QTRX insiders bought $296K of stock on the open market and sold $0, according to SEC Form 4 filings.

AI Auto Pilots
Is QTRX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold QTRX.

Key Stats

Last 12 months
Results
Revenue
$148.2M
+13.8% vs a year ago
Net income
−$111.2M
−75.0% margin
EPS (diluted)
−$2.34
Free cash flow
−$56.0M
−37.8% margin
Valuation
Market cap
$93.1M
47.5M shares
P/E
–
No P/E while losing money
Price to sales
0.6
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$35.9M
At Sep 30
Shareholder equity
$219.3M
Shares outstanding
47.5M
At Nov 2
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $110.6M$110.6MFY2021FY2022: $105.5M$105.5MFY2022FY2023: $122.4M$122.4MFY2023FY2024: $137.4M$137.4MFY2024FY2025: $138.9M$138.9MFY2025

From QTRX's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 9). Last 12 months adds up the four latest quarters.

Next report
Mar 1
Estimated date · After the close
Reported EPS
-$0.46
Quarter ended Sep 2026
Year ago EPS
-$0.73
Same quarter last year
Revenue
$35.0M
−13.1% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.30Dec '24Mar 2025: -$0.53Mar '25Jun 2025: -$0.77Jun '25Sep 2025: -$0.73Sep '25Dec 2025: -$0.47Dec '25Mar 2026: -$0.37Mar '26Jun 2026: -$1.04Jun '26Sep 2026: -$0.46Sep '26Latest -$0.46
Revenue by quarter
Dec 2024: $35.2MDec '24Mar 2025: $30.3MMar '25Jun 2025: $24.5MJun '25Sep 2025: $40.2MSep '25Dec 2025: $43.9MDec '25Mar 2026: $36.4MMar '26Jun 2026: $32.9MJun '26Sep 2026: $35.0MSep '26Latest $35.0M
How QTRX moved after its last 8 reports
Average move the session after a report ±17.4%
Nov 9, 2026Time not announced+16.8%
Aug 10, 2026Time not announced−40.0%
May 6, 2026After the close−16.4%
Mar 2, 2026After the close−7.3%
Jan 8, 2026After the close+23.8%
Nov 10, 2025After the close−2.3%
Aug 7, 2025After the close−13.8%
May 12, 2025After the close−19.0%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on QTRXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on QTRX
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on QTRX

Technical Analysis

QTRX · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold

The stock is 44% below its 20 day and 54% below its 50 day average. It is 82% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 30), near oversold. The nearest support is the Pivot at $1.92, and the nearest resistance the Pivot R1 at $2.07.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 14.8%/day
Key levels
$8.7752 week high+347.4%
$3.57200 day average+82.1%
$3.16100 day average+61.2%
$3.0250 day average+54.1%
$2.8320 day average+44.4%
$2.83Swing high (Sep 8)+44.4%
$2.07Pivot R1+5.6%
$1.96Last close
$1.92Pivot−2.0%
$1.81Pivot S1−7.7%
$1.7652 week low−10.2%
Indicators
RSI (14)30.40Weak, oversold below 30Neutral
MACD-0.21Below its signal lineBearish
Stochastic9.3Near the bottom of its rangeOversold
ADX (14)18.1No clear trend
Williams %R-89.0Oversold below −80, overbought above −20Oversold
CCI (20)-252.4Oversold below −100, overbought above 100Oversold
Rate of change−32.3%Change over 10 sessionsBearish
ATR (14)$0.29Typical daily range, 14.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for QTRX

What happened before

See how QTRX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow QTRX usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How QTRX has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2017.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for QTRXHow many large options trades hit QTRX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

QTRX Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bearish
Strongly bearishNeutralStrongly bullish
  • ▼56 buying vs 67 selling
  • ▼Held by funds -4.7 pts
  • ▼Funds holding -10
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding123133−7.5%
In funds' top 10220.0%
Held by funds63.0%67.8%−4.7 pts
New / increased14 / 4236 / 44−30.0%
Reduced / sold out44 / 2329 / 31+11.7%
Put/call ratio–0.00–
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See QTRX institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

QTRX Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$296K2 buys · 2 insiders
Sold$00 sales · 0 insiders
2026-05 bought $10K2026-08 bought $286KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Aug 13William P DonnellyDirectorBuy99,400$2.88$286K
May 12Benjamin MeadowsChief Commercial OfficerBuy3,500$2.77$10K
Sep 12, 2025Vandana SriramCFOBuy4,150$4.79$20K
Jun 13, 2025David R WaltDirectorBuy160,000$6.16$986K
Jun 9, 2025Masoud TolouePresident & CEOBuy45,900$5.42$249K
Jun 9, 2025David R WaltDirectorBuy210,000$5.40$1.1M
Every insider buy and sale for QTRX over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See QTRX insider trades →

From SEC Form 4 filings by QTRX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether QTRX is in one of them and how their past QTRX trades turned out.

QTRX in the AI portfolios
Loading…

QTRX News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered QTRX in an article yet. Here's the latest on the wider market.

QTRX in the news

About Quanterix

Quanterix is a life sciences company based in Billerica, Massachusetts. It makes highly sensitive instruments, consumables and spatial biology platforms that detect proteins and other biomarkers in blood, other fluids and tissue samples. Its customers include research laboratories, contract research organizations, academic institutions and biopharmaceutical companies. The company also offers contract research and clinical lab testing services through a laboratory in Bedford, Massachusetts.

Headquarters
Billerica, MA
Founded
2007